Caption Management, LLC Adverum Biotechnologies, Inc. Transaction History

Caption Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$9.26 - $14.36 $104,313 - $161,765	-11,265 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$9.84 - $14.26 $110,847 - $160,638	11,265 New	11,265 $123,000
Q2 2020 Aug 14, 2020	SELL	$8.53 - $25.64 $153,540 - $461,520	-18,000 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$7.98 - $16.32 $466,032 - $953,088	-58,400 Reduced 76.44%	18,000 $176,000
Q4 2019 Feb 13, 2020	SELL	$5.12 - $12.22 $247,808 - $591,448	-48,400 Reduced 38.78%	76,400 $880,000
Q3 2019 Nov 14, 2019	BUY	$5.24 - $15.89 $653,952 - $1.98 Million	124,800 New	124,800 $681,000

524K

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $424M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.